LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Other Financing Activities
Financing cash flows not reported separately.
LENSAR, Inc.NASDAQ: LNSR
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities dips below year-ago levels
Q1 FY2026 other financing activities of $224K (cash outflow) fell 32.1% year over year, behind the +82.3% change in trailing-twelve-month other financing activities.
Context
- Other financing activities amounted to 17.1% of revenue in FY2025, up 17.1 pp from a year earlier.
- Other financing activities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -32.1% toward the trailing-twelve-month pace of +82.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- 10M USD
- Year-over-year change
- +49900.0%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10M | +49900.0% |
| FY2024 | 2024-12-31 | 20K | -99.7% |
| FY2023 | 2023-12-31 | 5.88M | +345.0% |
| FY2022 | 2022-12-31 | (2.4M) | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Financing Activities vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 other financing activities of $319K is the 7th largest of the 10 companies compared; the peer median is $941K.
- Its year-over-year change of +82.3% is the highest of 9, against a peer median of -44.6%.
- Other financing activities amounts to 0.6% of revenue for LNSR, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3M | +26.4% | — | 2.8% | |
| LTM Mar 2026 | $1.76M | -42.3% | — | 3.9% | |
| LTM Mar 2026 | $1.74M | +18.3% | -33.2% | 1.5% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $1.17M | -47.0% | +5.4% | 63.0% |
| LTM Mar 2026 | $941K | -70.7% | — | 5.0% | |
| LTM Mar 2026 | $852K | -286.8% | — | 2.5% | |
| LTM Mar 2026 | $319K | +82.3% | — | 0.6% | |
| LTM Mar 2026 | $25K | +31.6% | — | 4.8% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | — | |
| Peer median (excluding LNSR) | $941K | -44.6% | -13.9% | 3.4% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.